Evaluating Success of Current Treatments for HCM

Slides:



Advertisements
Similar presentations
Date of download: 7/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Contemporary Natural History and Management of Nonobstructive.
Advertisements

Evolving Standards in HER2-Targeted Adjuvant Therapy for Breast Cancer
The Nurse View: Management of Pancreatic Cancer
Perspectives on Managing Polycythemia Vera for the Nurse Practitioner and Physician Assistant.
Endocrine Combinations in HR-Positive MBC: The Future Is Now
The Nurse View.
Latest Advances in HCM.
COPD.
Bipolar I Depression Today: The Evolving Understanding of Bipolar Depression Neurobiology and the Relation to Diagnosis.
Pharmacy Perspectives in Multiple Myeloma: Relapsed and/or Refractory Disease.
Post-autologous Transplant Therapy for Hodgkin Lymphoma
Relapsed/Refractory Follicular Lymphoma Conundrums
The Clinical Enigma of Cardiogenic Shock
Exploring the Spectrum of Excessive Daytime Sleepiness
Progression After Cancer Immunotherapy in Advanced NSCLC
At The Cutting Edge of Developments in the Management of Hyperkalemia
Understanding the Many Faces of Pseudobulbar Affect
Standards of Care in Duchenne Muscular Dystrophy: A 2018 Update
Program Goals. Targeting New Pathways for Overcoming Endocrine Resistance in Breast Cancer.
What Is New in HCM?.
Optimizing the Treatment of Recurrent/Metastatic SCCHN
Case Challenges in Chronic Migraine
New Treatments for CTEPH
The Mood Disorder Spectrum
A Focus on Polycythemia Vera for Nurse Practitioners and Physician Assistants.
Improving Risk Assessment and Early Diagnosis in PAH
Updates in Neuronal Ceroid Lipofuscinosis
VTE Treatment Conventional Approach
Multidisciplinary Perspectives on Interstitial Lung Diseases
Program Goals. Treatment-Naive Patients With PAH What Do We Know and What Choices Do We Have?
Gene Therapy: Past, Present, and Future
2013 World Symposium on PH CTEPH Diagnosisa 2013 World Symposium on PH (cont) CTEPH Treatmenta.
Essential Concepts in the Use of Immunotherapies in Bladder Cancer
Ask the Experts.
Immunotherapy for cSCC
When Shortness of Breath Is NOT Asthma
EARLY Combination Therapy in PAH: What Every Cardiologist Needs to Know.
Nonobstructive Hypertrophic Cardiomyopathy Out of the Shadows: Known from the Beginning but Largely Ignored … Until Now  Barry J. Maron, MD, Ethan J.
Nurse View: Practice Pearls in Advanced Pancreatic Adenocarcinoma
Personalizing Management in the Care of Patients With Advanced Sarcoma
The Evolving Treatment Landscape in Atopic Dermatitis
Updates in Seizure Management
The Road to Quality Improvement in HER2-Positive Breast Cancer
When Is Intrathecal Drug Delivery Appropriate?
Treatment-Resistant Schizophrenia
Implications of Emerging Treatments for Beta-Thalassemia
EGPA.
Updates in Neuronal Ceroid Lipofuscinosis
Managing Patients with Relapsed CLL who Discontinue BCR Signaling Inhibitors.
Patient Questions and Expert Answers in Psoriasis:
Are We Making Progress in the Management of Huntington Disease?
Proteasome Inhibitors and Patients
Incorporating Prostacyclins Into Practice
Debates and Dilemmas, Part 1
Improving Outcomes in Patients With SSc-ILD
A Family Affair.
Peanut Allergy Immunotherapy
When Is Intrathecal Drug Delivery Appropriate?
Prostacyclin Pathway Agents in Action
Optimizing Outcomes for Patients With Systemic Lupus Erythematosus: Key Considerations.
This program will include a discussion of off-label treatment or use of investigational agents not approved by the FDA for use in the US, and data that.
AMD Therapy: Where Are We Now and Where Are We Going?
Binge Eating Disorder.
Clinical Comparisons in CTEPH
Championing Evidence-Based Care in Patients With Acute Low Back Pain
Widening the Options for Major Depressive Disorder
Case Study #1. Management of Heart Failure With Comorbidities: Challenging Cases for the Cardiologist.
Understanding the Basics of Dementia-Related Psychosis
Management of NTM Lung Disease
Diagnosing HFpEF: What Every Cardiologist Needs to Know
Presentation transcript:

Evaluating Success of Current Treatments for HCM

Hypertrophic Cardiomyopathy (HCM)

HCM Prevalence

Diagnosis Process

Identifying HCM

Nonspecific Symptoms of HCM

MOGE(S) Classification of Cardiomyopathies

Heterogeneous HCM -- A Broad Term

Diagnostic Challenges

Case Presentation

Case Presentation (cont)

Case Presentation (cont)

Case Presentation (cont)

Disease Pathway

Obstruction Is Associated With Symptom Progression in HCM

Treatment Algorithm for Obstructive HCM

Case Presentation (cont) Treatment Approach

No HCM-Specific Treatments to Date

Nonobstructive HCM

More Options for Obstructive HCM Invasive Septal Reduction Therapy

Investigational Therapies

Mavacamten (MYK-461)

PIONEER-HCM (Phase 2 Study) Mavacamten Reduces LVOT Gradients

PIONEER-HCM (Phase 2 Study) Improvement in Symptoms and Functional Capacity

Ongoing Trials in Obstructive HCM and NOHCM

PIONEER-OLE Positive Six-Month Safety and Efficacy Data

Conclusion

Abbreviations

Abbreviations (cont)